Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:focuses_on |
Healthcare Investments
|
| gptkbp:founded |
Jim Tananbaum
|
| gptkbp:headquarters |
gptkb:San_Francisco,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Foresite Capital
|
| gptkbp:investment |
gptkb:Freenome
gptkb:Zymergen gptkb:healthcare_organization gptkb:hospital gptkb:Company gptkb:Insurance_Company Pharmaceuticals Diagnostics Early Stage Investments Growth Stage Investments GRAIL EQ Rx |
| gptkbp:partnership |
gptkb:Harvard_University
gptkb:Massachusetts_Institute_of_Technology gptkb:Stanford_University gptkb:Scripps_Research_Institute gptkb:Nant_Works Jim Tananbaum |
| gptkbp:production_company |
gptkb:Molecular_Templates
gptkb:Sutro_Biopharma gptkb:Tessera_Therapeutics gptkb:Cure_Vac gptkb:Nant_Kwest Aviir Syndax Pharmaceuticals TC R2 Therapeutics |
| gptkbp:receives_funding_from |
$1 billion
|
| gptkbp:website |
foresitecapital.com
|
| gptkbp:year_created |
gptkb:2011
|
| gptkbp:bfsParent |
gptkb:Spark_Therapeutics
|
| gptkbp:bfsLayer |
4
|